Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial - Concepedia

Concepedia

Publication | Closed Access

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial

290

Citations

17

References

2014

Year

Robert E. Coleman, David Cameron, David Dodwell, Richard H. Bell, Caroline Wilson, Emma Rathbone, Maccon Keane, Miguel Gil‐Gil, Roger Burkinshaw, Robert Grieve,

The Lancet Oncology

Breast OncologyEarly Breast CancerMedicineCancer ManagementPharmacologyClinical TrialsBreast CancerPharmacotherapyCancer TreatmentOncologyAdjuvant Zoledronic AcidFinal Efficacy Analysis

References

	Year	Citations

Page 1

Page 1